CN103961466A - Oral prescription for treating xerophthalmia - Google Patents
Oral prescription for treating xerophthalmia Download PDFInfo
- Publication number
- CN103961466A CN103961466A CN201410168408.XA CN201410168408A CN103961466A CN 103961466 A CN103961466 A CN 103961466A CN 201410168408 A CN201410168408 A CN 201410168408A CN 103961466 A CN103961466 A CN 103961466A
- Authority
- CN
- China
- Prior art keywords
- parts
- fructus
- weight
- xerophthalmia
- oral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the technical field of Chinese medicines, and in particular relates to an oral prescription for treating xerophthalmia. The oral prescription is prepared by mixing the following traditional Chinese medicine raw materials in parts by weight: 5-10 parts of fructus lycii, 10-25 parts of forsythia, 5-10 parts of felwort, 5-10 parts of pearl powder, 10-15 parts of groundsel, 5-10 parts of cassia seed, 10-15 parts of prepared rehmannia root, 5-8 parts of cortex moutan, and 5-15 parts of dogwood. The raw materials are weighted according to the weight parts, and are decocted with water for taking; the medicine is taken one dose a day, and the dose is taken orally in three times; the medicine takes effect quickly for treating xerophthalmia, is high in cure rate and has small toxic and side effects.
Description
Technical field
The invention belongs to Chinese medicine technical field, particularly a kind of oral prescription for the treatment of xerophthalmia.
Background technology
Xerophthalmia refers to tear matter that any reason causes or amount is abnormal or kinetics is abnormal, causes tear film stability to decline, and with the general name of the various diseases of ophthalmic uncomfortable and (or) eye table organization characteristics of lesion.Claim again angle conjunctival xerosis.Common sympton comprise eyes dry and astringent, easily tired, ophthalmic pruritus, have that foreign body sensation, pain burning sensation, secretions are sticky, aversion to wind, photophobia, to external world stimulate very sensitive; Sometimes eyes are too dry, and basic oligodacrya, stimulates reflexive lacrimal secretion on the contrary, sheds tears and usually cause.Cannot treat for xerophthalmia operation, medicine does not have clear and definite curative effect yet, and the treatment difficulty of getting up is larger.
Summary of the invention
The oral prescription that the object of this invention is to provide a kind for the treatment of xerophthalmia of Chinese medicine preparation, has instant effect, the advantage that cure rate is high, toxic and side effects is little, and there is simple and easy to do preparation method.
The invention provides a kind of collyrium for the treatment of conjunctivitis, it is characterized in that by the raw material of Chinese medicine of following parts by weight formulated: 5～10 parts of Fructus Lycii, 10～25 parts of Fructus Forsythiaes, 5～10 parts of Radix Gentianaes, 5～10 parts of Margarita powder, 10～15 parts of Herba Senecionis Scandentiss, 5～10 parts of Semen Cassiaes, 10～15 parts of Radix Rehmanniae Preparata, 5～8 parts of Cortex Moutans, 5～15 parts of Fructus Corni.
More preferably formulated by the raw material of Chinese medicine of following parts by weight: 8 parts of Fructus Lycii, 10 parts of Fructus Forsythiaes, 6 parts of Radix Gentianaes, 6 parts of Margarita powder, 10 parts of Herba Senecionis Scandentiss, 8 parts of Semen Cassiaes, 10 parts of Radix Rehmanniae Preparata, 6 parts of Cortex Moutans, 10 parts of Fructus Corni.
Instructions of taking is to take raw material by above-mentioned parts by weight, be decocted in water for oral dose, every day potion, points three times are oral.
Pharmacology analysis:
Fructus Lycii: cure mainly nourishing the liver and kidney, replenishing vital essence to improve eyesight.For asthenia damage of essence, soreness of waist and knee joint, vertigo and tinnitus, interior-heat is quenched one's thirst, blood deficiency and yellow complexion, blurred vision is not clear.
Fructus Forsythiae: antibacterial, antiinflammatory, antipyretic, tell in town, diuresis heart tonifying, anti-liver damage, analgesia, suppress phosphodiesterase, antiviral, blood pressure lowering, inhibition elastin laminin enzyme activity, antiendotoxin.
Radix Gentianae: heat clearing and damp drying, eliminating pathogen in the liver arresting convulsion.The feeling of fullness in the head headache for the treatment of liver and gall excess-fire; Conjunctival congestion and swelling pain; Deaf ear is swollen; Hypochondriac pain bitter taste; Calentura infantile convulsion.
Margarita powder: the arresting convulsion of calming the nerves, improving eyesight removing nebula, removing toxic substances and promoting granulation.
Herba Senecionis Scandentis: it is cold in nature, bitter in the mouth, has heat-clearing and toxic substances removing, improving eyesight, the effect such as antipruritic.
Semen Cassiae: bitter in the mouth, sweet and cool in nature, has clearing away liver-fire, wind-damp dispelling, tonifying kidney and improving eyesight.
Radix Rehmanniae Preparata: sweet, tepor.Return liver, kidney channel.Enter blood system, matter is soft and moist falls.
Cortex Moutan: main cold and heat, go convulsion, infantile convulsion pathogen, except the hard blood stasis of disease stays house the intestines and stomach, settling five organs, treats carbuncle skin ulcer.
Fructus Corni: for vertigo and tinnitus, soreness of waist and knee joint, impotence and seminal emission, enuresis frequent micturition, bleeding not during menses, profuse sweating collapse
The present invention is Chinese medicine preparation sheerly, proves through years of researches and clinical practice: instant effect, cure rate is high, drug safety is reliable, medicine valency is cheap, has avoided toxic and side effects and the anaphylaxis of chemicals.Preparation method is simple and easy to do, easily implements.
Curative effect judgement:
Dry eye symptoms is: eyes are dry and astringent, easily tired, ophthalmic pruritus, have that foreign body sensation, pain burning sensation, secretions are sticky, aversion to wind, photophobia, to external world stimulate very sensitive; Sometimes eyes are too dry, and basic oligodacrya, stimulates reflexive lacrimal secretion on the contrary, sheds tears and usually cause.
Recovery from illness: symptom disappears completely, without dry and astringent and foreign body sensation, can be to environmental stimulis such as anti-light, wind.
Take a turn for the better: symptom disappears substantially, the symptoms such as dry and astringent, foreign body sensation are obviously alleviated.
Invalid: all diseases are without improvement.
Therapeutic outcome: treatment conjunctivitis patient 202 examples, take medicine of the present invention, be decocted in water for oral dose, every day potion, points three times are oral.If feel Liver and kidney portion discomfort, nervous uncomfortable in chest, have stopping using immediately of allergic symptom, Pregnant and lactant women should be cautious use of.Treat after 2～4 weeks, recovery from illness 171 examples, account for 85%, and 31 examples that take a turn for the better, account for 15%.
Attached several routine case is described further:
Case 1: bent certain, man, 42 years old, suffer from xerophthalmia 2 years, take medicine of the present invention and take effect for 2 weeks, 3 weeks afterwards symptom disappear completely, can be engaged in normal work.Follow up a case by regular visits to 3 years without recurrence.
Case 2: king so-and-so, female, 27 years old, suffer from xerophthalmia 1 year, repeated multiple times, use to change to take 3 weeks symptoms of medicine of the present invention and obviously improve, after 4 weeks, symptom disappears completely, follows up a case by regular visits to 5 years without recurring.
Detailed description of the invention
Embodiment 1:
8 parts of Fructus Lycii, 10 parts of Fructus Forsythiaes, 6 parts of Radix Gentianaes, 6 parts of Margarita powder, 15 parts of Herba Senecionis Scandentiss, 8 parts of Semen Cassiaes, 10 parts of Radix Rehmanniae Preparata, 6 parts of Cortex Moutans, 10 parts of Fructus Corni.
Instructions of taking is to take raw material by above-mentioned parts by weight, be decocted in water for oral dose, every day potion, points three times are oral, take 2 weeks.
Embodiment 2:
5 parts of Fructus Lycii, 20 parts of Fructus Forsythiaes, 10 parts of Radix Gentianaes, 5 parts of Margarita powder, 10 parts of Herba Senecionis Scandentiss, 5 parts of Semen Cassiaes, 15 parts of Radix Rehmanniae Preparata, 5 parts of Cortex Moutans, 15 parts of Fructus Corni.
Instructions of taking is to take raw material by above-mentioned parts by weight, be decocted in water for oral dose, every day potion, points three times are oral, take 3 weeks.
Embodiment 3:
10 parts of Fructus Lycii, 25 parts of Fructus Forsythiaes, 5 parts of Radix Gentianaes, 10 parts of Margarita powder, 15 parts of Herba Senecionis Scandentiss, 10 parts of Semen Cassiaes, 10 parts of Radix Rehmanniae Preparata, 8 parts of Cortex Moutans, 5 parts of Fructus Corni.
Instructions of taking is to take raw material by above-mentioned parts by weight, be decocted in water for oral dose, every day potion, points three times are oral, take 3 weeks.
Claims (2)
1. an oral prescription for the treatment of xerophthalmia, is characterized in that: the raw material of Chinese medicine by following parts by weight is formulated: 5～10 parts of Fructus Lycii, 10～25 parts of Fructus Forsythiaes, 5～10 parts of Radix Gentianaes, 5～10 parts of Margarita powder, 10～15 parts of Herba Senecionis Scandentiss, 5～10 parts of Semen Cassiaes, 10～15 parts of Radix Rehmanniae Preparata, 5～8 parts of Cortex Moutans, 5～15 parts of Fructus Corni.
2. the oral prescription for the treatment of xerophthalmia as claimed in claim 1, is characterized in that: the raw material of Chinese medicine by following parts by weight is formulated: 8 parts of Fructus Lycii, 10 parts of Fructus Forsythiaes, 6 parts of Radix Gentianaes, 6 parts of Margarita powder, 10 parts of Herba Senecionis Scandentiss, 8 parts of Semen Cassiaes, 10 parts of Radix Rehmanniae Preparata, 6 parts of Cortex Moutans, 10 parts of Fructus Corni.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410168408.XA CN103961466A (en) | 2014-04-24 | 2014-04-24 | Oral prescription for treating xerophthalmia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410168408.XA CN103961466A (en) | 2014-04-24 | 2014-04-24 | Oral prescription for treating xerophthalmia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103961466A true CN103961466A (en) | 2014-08-06 |
Family
ID=51231786
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410168408.XA Pending CN103961466A (en) | 2014-04-24 | 2014-04-24 | Oral prescription for treating xerophthalmia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103961466A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4129316A4 (en) * | 2020-04-24 | 2023-11-01 | Smilebiotek Guangzhou Limited | Application of radix gentianae macrophyllae and monomer compound thereof in killing mites |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1775261A (en) * | 2005-11-18 | 2006-05-24 | 北京阜康仁生物制药科技有限公司 | Mingmu-Dihuang preparation and new preparing method |
| CN101843781A (en) * | 2010-05-28 | 2010-09-29 | 郑州市新视明科技工程有限公司 | Chinese medicinal composition for preventing and treating xerophthalmia |
| CN102488756A (en) * | 2011-12-09 | 2012-06-13 | 田明霞 | Medicament for treating dry eye syndrome |
-
2014
- 2014-04-24 CN CN201410168408.XA patent/CN103961466A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1775261A (en) * | 2005-11-18 | 2006-05-24 | 北京阜康仁生物制药科技有限公司 | Mingmu-Dihuang preparation and new preparing method |
| CN101843781A (en) * | 2010-05-28 | 2010-09-29 | 郑州市新视明科技工程有限公司 | Chinese medicinal composition for preventing and treating xerophthalmia |
| CN102488756A (en) * | 2011-12-09 | 2012-06-13 | 田明霞 | Medicament for treating dry eye syndrome |
Non-Patent Citations (1)
| Title |
|---|
| 张骠: "《免疫功能减退中医治疗》", 30 April 2004 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4129316A4 (en) * | 2020-04-24 | 2023-11-01 | Smilebiotek Guangzhou Limited | Application of radix gentianae macrophyllae and monomer compound thereof in killing mites |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101773653B (en) | Chinese medicine composition for treating ablepsia and preparation method thereof | |
| CN103735721B (en) | A kind of Chinese medicine treating pink-eye | |
| CN103638250B (en) | One treats prosopoplegic Chinese medicine preparation and preparation method thereof | |
| CN103405728A (en) | Traditional Chinese medicine composition for treating climacteric syndrome and preparation method thereof | |
| CN102755593A (en) | Traditional Chinese medicine composition for treating qi goiter and preparation method thereof | |
| CN104606615A (en) | Traditional Chinese medicine eyedrop for treating ocular inflammation and preparation method thereof | |
| CN104436040A (en) | Medicine for treating xerophthalmia | |
| CN103520649B (en) | The Chinese medicine for the treatment of facial neuritis | |
| CN104587043A (en) | Traditional Chinese medicine eye drops for treating ocular inflammation and preparation method thereof | |
| CN104784346A (en) | Pruritus treating traditional Chinese medicine lotion preparation method | |
| CN103301431A (en) | Traditional Chinese medicinal preparation for treating glaucoma and preparation method thereof | |
| CN103961466A (en) | Oral prescription for treating xerophthalmia | |
| CN103877424B (en) | A kind of Chinese medicine liquid medicine and preparation method for the treatment of trachoma | |
| CN104606395A (en) | Traditional Chinese medicine prescription treating menstrual fever | |
| CN103610797B (en) | Traditional Chinese medicine composition for treating keratoconjunctivitis due to congestion and excess of dampness-heat | |
| CN104027464B (en) | A kind of Chinese drugs agentia treating chronic conjunctivitis and preparation method thereof | |
| CN102631633B (en) | Preparation method for traditional Chinese medicine wash lotion for treating constipation type acute lymphangitis | |
| CN102626503B (en) | Chinese medicinal oral liquid for smoothing heart and enhancing intelligence | |
| CN100546607C (en) | The leukodermic Chinese medicine preparation of a kind of treatment | |
| CN105726984A (en) | Traditional Chinese medicine eye drops for treating eye inflammation and preparation method thereof | |
| CN105727132A (en) | Traditional Chinese medicine eye drops for treating eye inflammation and preparation method thereof | |
| CN104474289A (en) | Traditional Chinese medicine eye drops for treating ocular inflammation and preparation method thereof | |
| CN104474439A (en) | Traditional Chinese medicine eye drops for treating ocular inflammation and preparation method thereof | |
| CN105582243A (en) | Traditional Chinese medicine composition for treating solar dermatitis | |
| CN104771638A (en) | Traditional Chinese medicine composition for treating optic atrophy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140806 |
|
| RJ01 | Rejection of invention patent application after publication |